Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Pediatrix Medical (MD) Restructuring Costs (2019 - 2025)

Historic Restructuring Costs for Pediatrix Medical (MD) over the last 7 years, with Q3 2025 value amounting to $6.0 million.

  • Pediatrix Medical's Restructuring Costs fell 6792.03% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.0 million, marking a year-over-year decrease of 654.56%. This contributed to the annual value of $64.3 million for FY2024, which is 279589.91% up from last year.
  • As of Q3 2025, Pediatrix Medical's Restructuring Costs stood at $6.0 million, which was down 6792.03% from $3.8 million recorded in Q2 2025.
  • Over the past 5 years, Pediatrix Medical's Restructuring Costs peaked at $23.6 million during Q4 2024, and registered a low of $977000.0 during Q3 2022.
  • Its 5-year average for Restructuring Costs is $8.3 million, with a median of $5.6 million in 2022.
  • Its Restructuring Costs has fluctuated over the past 5 years, first crashed by 8866.47% in 2023, then soared by 96538.98% in 2024.
  • Over the past 5 years, Pediatrix Medical's Restructuring Costs (Quarter) stood at $3.1 million in 2021, then soared by 540.16% to $19.6 million in 2022, then tumbled by 88.66% to $2.2 million in 2023, then surged by 965.39% to $23.6 million in 2024, then tumbled by 74.81% to $6.0 million in 2025.
  • Its last three reported values are $6.0 million in Q3 2025, $3.8 million for Q2 2025, and $6.6 million during Q1 2025.